Transrectal ultrasound-guided biopsy for prostate cancer detection: Systematic and/or magnetic-resonance imaging-targeted.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published Date: Sep 1, 2017

Abstract

INTRODUCTION: Magnetic resonance imaging (MRI) is being more widely used in the detection of prostate cancer (PCa), particularly after an initial negative biopsy. In this study, we compared 12-core systematic biopsy (SYS), MRI-targeted biopsy (TAR), and the association of systematic and MRI-targeted (SYS+TAR) prostate biopsy in patients with previous biopsy and those who were biopsy-naive to evaluate the differences in terms of cancer detection and clinically significant cancer detection between the three modalities.

Authors

  • Franck Bladou
    Department of Urology; Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Cora Fogaing
    Department of Urology; Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Mark Levental
    Department of Radiology; Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Samuel Aronson
    Department of Urology; Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Mona Alameldin
    Department of Pathology; Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Maurice Anidjar
    Department of Urology; Jewish General Hospital, McGill University, Montreal, QC, Canada.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals